Stryker (NYSE:SYK) Insider Sells $277,783.80 in Stock

Stryker Corporation (NYSE:SYK) insider Debra King sold 826 shares of the company’s stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $336.30, for a total value of $277,783.80. Following the sale, the insider directly owned 6,210 shares of the company’s stock, valued at approximately $2,088,423. This represents a 11.74% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Stryker Stock Performance

NYSE:SYK opened at $327.97 on Friday. The company has a debt-to-equity ratio of 0.59, a current ratio of 2.16 and a quick ratio of 1.33. The firm has a market cap of $125.80 billion, a price-to-earnings ratio of 33.99, a price-to-earnings-growth ratio of 2.17 and a beta of 0.76. The firm’s fifty day moving average price is $326.64 and its 200 day moving average price is $332.66. Stryker Corporation has a 1-year low of $281.00 and a 1-year high of $396.86.

Stryker (NYSE:SYK) last released its earnings results on Thursday, July 30th. The medical technology company reported $3.69 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.49 by $0.20. Stryker had a return on equity of 23.63% and a net margin of 14.43%.The company had revenue of $6.59 billion for the quarter, compared to analysts’ expectations of $6.58 billion. During the same quarter in the previous year, the firm posted $3.13 EPS. The firm’s quarterly revenue was up 9.4% on a year-over-year basis. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. On average, sell-side analysts expect that Stryker Corporation will post 15.02 EPS for the current year.

Stryker Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be paid a $0.88 dividend. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $3.52 dividend on an annualized basis and a yield of 1.1%. Stryker’s dividend payout ratio is presently 36.48%.

Institutional Trading of Stryker

A number of institutional investors have recently added to or reduced their stakes in SYK. Norges Bank acquired a new stake in shares of Stryker in the 4th quarter valued at about $1,822,272,000. Bank of America Corp DE acquired a new position in Stryker in the second quarter worth about $1,404,284,000. Auto Owners Insurance Co grew its stake in Stryker by 35,047.0% in the fourth quarter. Auto Owners Insurance Co now owns 2,914,741 shares of the medical technology company’s stock worth $1,024,444,000 after purchasing an additional 2,906,448 shares in the last quarter. Legal & General Group Plc bought a new stake in Stryker in the second quarter valued at about $707,212,000. Finally, Jupiter Topco LLC acquired a new stake in Stryker during the second quarter valued at approximately $681,581,000. 77.09% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several brokerages recently issued reports on SYK. Wells Fargo & Company reduced their price objective on shares of Stryker from $456.00 to $418.00 and set an “overweight” rating on the stock in a research note on Friday, May 1st. Barclays lowered their target price on shares of Stryker from $469.00 to $394.00 and set an “overweight” rating for the company in a research note on Monday, May 4th. Wolfe Research lowered Stryker from an “outperform” rating to a “peer perform” rating in a research note on Thursday, August 13th. JPMorgan Chase & Co. decreased their price objective on Stryker from $400.00 to $350.00 and set an “overweight” rating on the stock in a report on Friday, July 31st. Finally, Piper Sandler lowered their price objective on Stryker from $420.00 to $390.00 and set an “overweight” rating for the company in a research report on Friday, July 31st. One investment analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat, Stryker has an average rating of “Moderate Buy” and an average target price of $386.28.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.